Zamora et al. also demonstrated a gradual decline in SSTR1 expression of well- and poorly differentiated neuroendocrine tumors, with a frequency of 46% and 25% of the cases, respectively [27]. The gene discussed is SSTR1; the disease is neuroendocrine neoplasm.